These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The use of a single non-timed urine collection in the calculation of fractional lithium clearance. O'Hagan M; Greene S Eur J Clin Pharmacol; 1990; 39(1):89-90. PubMed ID: 2276392 [TBL] [Abstract][Full Text] [Related]
3. Intravenous ciprofloxacin disposition in obesity. Allard S; Kinzig M; Boivin G; Sörgel F; LeBel M Clin Pharmacol Ther; 1993 Oct; 54(4):368-73. PubMed ID: 8222478 [TBL] [Abstract][Full Text] [Related]
4. Single dose pharmacokinetics of lithium and prediction of maintenance dose in manic depressive patients. Valecha N; Tayal G; Tripathi KD Indian J Med Res; 1990 Dec; 92():409-16. PubMed ID: 2079355 [TBL] [Abstract][Full Text] [Related]
7. Prediction and Comparison of Fentanyl Infusion Pharmacokinetics in Obese and Nonobese Children. Lim SY; Woo S; Miller JL; Skrepnek GH; Henry ED; Johnson PN Pediatr Crit Care Med; 2019 Dec; 20(12):e556-e564. PubMed ID: 31568259 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial infections. Pai MP; Cojutti P; Pea F Clin Pharmacokinet; 2015 Sep; 54(9):933-41. PubMed ID: 25850987 [TBL] [Abstract][Full Text] [Related]
16. Improving lithium dose prediction using population pharmacokinetics and pharmacogenomics: a cohort genome-wide association study in Sweden. Millischer V; Matheson GJ; Bergen SE; Coombes BJ; Ponzer K; Wikström F; Jagiello K; Lundberg M; Stenvinkel P; Biernacka JM; Breuer O; Martinsson L; Landén M; Backlund L; Lavebratt C; Schalling M Lancet Psychiatry; 2022 Jun; 9(6):447-457. PubMed ID: 35569502 [TBL] [Abstract][Full Text] [Related]
17. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay. Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic study and cardiovascular monitoring of nebivolol in normal and obese subjects. Cheymol G; Woestenborghs R; Snoeck E; Ianucci R; Le Moing JP; Naditch L; Levron JC; Poirier JM Eur J Clin Pharmacol; 1997; 51(6):493-8. PubMed ID: 9112066 [TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients. Chung EK; Cheatham SC; Fleming MR; Healy DP; Shea KM; Kays MB J Clin Pharmacol; 2015 Aug; 55(8):899-908. PubMed ID: 25823963 [TBL] [Abstract][Full Text] [Related]